A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity.

Banzato, Alessandra

A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2008 - 3598-606 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1078-0432

10.1158/1078-0432.CCR-07-2019 doi


Animals
Antineoplastic Agents--administration & dosage
Female
Flow Cytometry
Humans
Hyaluronic Acid--administration & dosage
Infusions, Parenteral
Mice
Mice, SCID
Microscopy, Confocal
Ovarian Neoplasms--drug therapy
Paclitaxel--administration & dosage
Xenograft Model Antitumor Assays